UK markets closed

Recce Pharmaceuticals Ltd (RCE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5950-0.0150 (-2.46%)
At close: 04:10PM AEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from investing activities
Investments in property, plant and equipment
-140.454
-38.633
-40.345
-76.007
-5.944
Net cash used for investing activities
-569.16
-38.633
-40.345
-76.007
-5.944
Cash flows from financing activities
Debt repayment
-1,350
-
-
-
-1,350
Common stock issued
11,176
102.043
287.408
28,056
6,980
Common stock repurchased
-
-
-
-1,719
-
Other financing activities
-150.107
-274.504
-527.907
-214.897
-150.107
Net cash used provided by (used for) financing activities
11,738
2,706
-240.499
26,123
6,092
Net change in cash
2,160
-10,020
-9,291
18,191
2,279
Cash at beginning of period
1,849
11,582
20,873
2,682
403.384
Cash at end of period
4,009
1,562
11,582
20,873
2,682
Free cash flow
Capital expenditure
-140.454
-38.633
-40.345
-76.007
-5.944
Free cash flow
-9,149
-12,726
-9,051
-7,932
-3,813